Prof. Dr. Nimet Yeşim ERÇALIK

1. Early visual response provides additional prognostic value beyond baseline OCT features in diabetic macular edema

KAPLAN F. B., ÖNDER TOKUÇ E., Bozkurt E., Özkaya A., Kanar H. S., SEVİK M. O., et al.

European Journal of Ophthalmology , 2026 (SCI-Expanded, Scopus)

2. Does completion time of the initiation phase of anti-vascular growth factor affect visual and anatomical outcomes?: The MARMASIA study group report No.5

Aydoğan Gezginaslan T., Özkaya A., SEVİK M. O., Saygın I. Ö., Limon U., Bozkurt E., et al.

Eye (Basingstoke) , cilt.39, sa.13, ss.2579-2583, 2025 (SCI-Expanded, Scopus)

3. Efficacy of ranibizumab and aflibercept on reducing maximum diameter of largest cyst in diabetic cystoid macular edema: MARMASIA study group

ÖNDER TOKUÇ E., Karabaş V. L., SEVİK M. O., KAPLAN F. B., Kutlutürk Karagöz I., Kanar H. S., et al.

European Journal of Ophthalmology , cilt.35, sa.3, ss.980-989, 2025 (SCI-Expanded, Scopus)

4. From infection prevention to injury: periorbital skin avulsion following cataract surgery

Sahinoglu Y. Z., Mangan M. S., ERÇALIK N. Y., ARICI C., Irmak A.

Clinical and Experimental Optometry , cilt.108, sa.7, ss.899-901, 2025 (SCI-Expanded, Scopus)

5. Evaluation of the effect of vitreomacular interface disorders on anti-VEGF treatment in patients with diabetic macular edema in real life: MARMASIA study group report No. 10

Bozkurt E., KAPLAN F. B., ÖNDER TOKUÇ E., AYKUT A., Özsoy Saygın I., Kanar H. S., et al.

International Ophthalmology , cilt.44, sa.1, 2024 (SCI-Expanded, Scopus)

6. Changes in pupil size, ocular wavefront aberrations, and accommodation in healthcare workers using FFP3 masks

ERÇALIK N. Y., Turkseven Kumral E., Mangan M. S., Alpogan O., Imamoglu S., Ozcelik Kose A., et al.

International Ophthalmology , cilt.43, sa.12, ss.4991-4996, 2023 (SCI-Expanded, Scopus)

7. Real-World Outcomes of Intravitreal Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema in Türkiye: MARMASIA Study Group Report No. 1

Yayla U., SEVİK M. O., Karabaş V. L., Şahin Ö., Özkaya A., Yenerel N. M., et al.

Turkish Journal of Ophthalmology , cilt.53, sa.6, ss.356-368, 2023 (Scopus, TRDizin)

8. Müller Muscle-Conjunctival Resection for Treatment of Contralateral Ptosis following Unilateral External Levator Advancement

Mangan M. S., Tekcan H., YURTTAŞER OCAK S., Ozcelik Kose A., Balci S., ERÇALIK N. Y., et al.

Plastic and Reconstructive Surgery , cilt.152, sa.3, ss.533-539, 2023 (SCI-Expanded, Scopus)

9. Analysis of risk factors and ocular hypotony characteristics in choroidal detachment after penetrating glaucoma surgery

ERÇALIK N. Y., Tekcan H., Mangan M. S., Ozcelik Kose A., Imamoglu S.

International Ophthalmology , cilt.42, sa.11, ss.3431-3440, 2022 (SCI-Expanded, Scopus)

10. The effect of uneventful cataract surgery in pseudoexfoliation glaucoma with or without previous mitomycin C-augmented trabeculectomy

Tekcan H., Mangan M. S., Alpogan O., Imamoglu S., Kose A. O., ERÇALIK N. Y.

International Ophthalmology , cilt.42, sa.11, ss.3531-3539, 2022 (SCI-Expanded, Scopus)

11. Efficacy of the Müller Muscle-Conjunctival Resection for the Correction of Unilateral Ptosis following External Levator Operations in Patients with Bilateral Involutional Ptosis

Mangan M. S., ÇAKIR A., ERÇALIK N. Y., Tekcan H., Balci S., Ozcelik Kose A., et al.

Plastic and Reconstructive Surgery , cilt.148, sa.2, 2021 (SCI-Expanded, Scopus)

12. Effects of Ab Interno XEN Gel Implantation on Postural Intraocular Pressure Elevations

Ozcelik Kose A., Esen F., Imamoglu S., ERÇALIK N. Y., Tekcan H., Kugu S.

Seminars in Ophthalmology , cilt.36, sa.3, ss.82-87, 2021 (SCI-Expanded, Scopus)

13. Analysis of ELOVL4 and PRPH2 genes in Turkish stargardt disease patients

Bardak H., GÜNAY M., ERÇALIK N. Y., Bardak Y., ÖZBAŞ H., BAĞCI Ö., et al.

Genetics and Molecular Research , cilt.15, sa.4, 2016 (Scopus)

Prof. Dr. Nimet Yeşim ERÇALIK

Yayınlar & Eserler

1. Early visual response provides additional prognostic value beyond baseline OCT features in diabetic macular edema

2. Does completion time of the initiation phase of anti-vascular growth factor affect visual and anatomical outcomes?: The MARMASIA study group report No.5

3. Efficacy of ranibizumab and aflibercept on reducing maximum diameter of largest cyst in diabetic cystoid macular edema: MARMASIA study group

4. From infection prevention to injury: periorbital skin avulsion following cataract surgery

5. Evaluation of the effect of vitreomacular interface disorders on anti-VEGF treatment in patients with diabetic macular edema in real life: MARMASIA study group report No. 10

6. Changes in pupil size, ocular wavefront aberrations, and accommodation in healthcare workers using FFP3 masks

7. Real-World Outcomes of Intravitreal Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema in Türkiye: MARMASIA Study Group Report No. 1

8. Müller Muscle-Conjunctival Resection for Treatment of Contralateral Ptosis following Unilateral External Levator Advancement

9. Analysis of risk factors and ocular hypotony characteristics in choroidal detachment after penetrating glaucoma surgery

10. The effect of uneventful cataract surgery in pseudoexfoliation glaucoma with or without previous mitomycin C-augmented trabeculectomy

11. Efficacy of the Müller Muscle-Conjunctival Resection for the Correction of Unilateral Ptosis following External Levator Operations in Patients with Bilateral Involutional Ptosis

12. Effects of Ab Interno XEN Gel Implantation on Postural Intraocular Pressure Elevations

13. Analysis of ELOVL4 and PRPH2 genes in Turkish stargardt disease patients

Yayın

Yayın (WoS)

Yayın (Scopus)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Proje

Tez Danışmanlığı

Açık Erişim